RNA Editing as a Biomarker of Antidepressant Response in Unipolar and Bipolar Depression (EDIT-ANDRE)

NCT07266545 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Unipolar Depression
Bipolar Depression

Interventions

DRUG: Vortioxetine
DRUG: Bupropion extended release
DRUG: Cariprazine (Augmentation Phase)

Sponsor

Mayo Clinic